The goal of the Developmental Core is to stimulate and support new investigator-initiated research breakthroughs in AIDS research through the support of CFAR faculty named in this application, those currently being actively recruited and those identified subsequently who would provide selected and high priority expertise. In order to achieve this, we have created a Developmental Core that possesses many unique characteristics. First, this Core will pursue its goal in the context of the matrix organization that exists at Duke reflecting a broad commitment to HIV/AIDS research and the opportunities to synergize across departments; second, the priorities identified reflect the overall CFAR scientific goals and complement and build on existing strengths; third, the Core will take advantage of the attractive recruitment packages for 5 high-level faculty over 5 years; fourth, the Core will provide """"""""seed"""""""" funds for small innovative grants and special projects and in so doing, strengthen internal programs; and fifth, foster cross disciplinary training through the identification of trainees and training opportunities not traditionally engaged in the conduct of HIV research . These unique characteristics reflect the innovative approach that we believe will maximize the effectiveness of the Developmental Core.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
5P30AI064518-02
Application #
7310270
Study Section
Special Emphasis Panel (ZAI1)
Project Start
Project End
Budget Start
2006-07-01
Budget End
2007-06-30
Support Year
2
Fiscal Year
2006
Total Cost
$415,492
Indirect Cost
Name
Duke University
Department
Type
DUNS #
044387793
City
Durham
State
NC
Country
United States
Zip Code
27705
Wiehe, Kevin; Bradley, Todd; Meyerhoff, R Ryan et al. (2018) Functional Relevance of Improbable Antibody Mutations for HIV Broadly Neutralizing Antibody Development. Cell Host Microbe 23:759-765.e6
McGuire, Erin P; Fong, Youyi; Toote, Christopher et al. (2018) HIV-Exposed Infants Vaccinated with an MF59/Recombinant gp120 Vaccine Have Higher-Magnitude Anti-V1V2 IgG Responses than Adults Immunized with the Same Vaccine. J Virol 92:
Skalski, Linda M; Towe, Sheri L; Sikkema, Kathleen J et al. (2018) Memory Impairment in HIV-Infected Individuals with Early and Late Initiation of Regular Marijuana Use. AIDS Behav 22:1596-1605
Mitchell, John T; LeGrand, Sara; Hightow-Weidman, Lisa B et al. (2018) Smartphone-Based Contingency Management Intervention to Improve Pre-Exposure Prophylaxis Adherence: Pilot Trial. JMIR Mhealth Uhealth 6:e10456
Okeke, Nwora Lance; Alenezi, Fawaz; Bloomfield, Gerald S et al. (2018) Determinants of Left Ventricular Hypertrophy and Diastolic Dysfunction in an HIV Clinical Cohort. J Card Fail 24:496-503
Clement, Meredith E; Seidelman, Jessica; Wu, Jiewei et al. (2018) An educational initiative in response to identified PrEP prescribing needs among PCPs in the Southern U.S. AIDS Care 30:650-655
Price, Alexander M; Messinger, Joshua E; Luftig, Micah A (2018) c-Myc Represses Transcription of Epstein-Barr Virus Latent Membrane Protein 1 Early after Primary B Cell Infection. J Virol 92:
Knettel, Brandon A; Cichowitz, Cody; Ngocho, James Samwel et al. (2018) Retention in HIV Care During Pregnancy and the Postpartum Period in the Option B+ Era: Systematic Review and Meta-Analysis of Studies in Africa. J Acquir Immune Defic Syndr 77:427-438
Cichowitz, Cody; Watt, Melissa H; Mmbaga, Blandina T (2018) Childbirth experiences of women living with HIV: a neglected event in the prevention of mother-to-child transmission care continuum. AIDS 32:1537-1539
Zhang, Helen L; Rhea, Sarah K; Hurt, Christopher B et al. (2018) HIV Preexposure Prophylaxis Implementation at Local Health Departments: A Statewide Assessment of Activities and Barriers. J Acquir Immune Defic Syndr 77:72-77

Showing the most recent 10 out of 488 publications